Moderna announces IND submitted to US FDA for phase 2 study of mRNA-1273 against novel coronavirus

Moderna has announced IND submitted to US FDA for phase 2 study of mRNA-1273 against novel coronavirus. (Credit: Pete Linforth from Pixabay)